1. Kaufman LD, Kephart GM, Seidman RJ, Buhner D, Qvarfordt I, Nässberger L, et al. The spectrum of eosinophilic myositis. Clinical and immunopathogenic studies of three patients, and review of the literature. Arthritis Rheum. 1993; 36:1014–1024.
2. Selva-O’Callaghan A, Trallero-Araguás E, Grau JM. Eosinophilic myositis: an updated review. Autoimmun Rev. 2014; 13:375–378.
3. Gotlib J. World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management. Am J Hematol. 2017; 92:1243–1259.
Article
4. Trüeb RM, Pericin M, Winzeler B, Wüthrich B, Burge G. Eosinophilic myositis/perimyositis: frequency and spectrum of cutaneous manifestations. J Am Acad Dermatol. 1997; 37:385–391.
Article
5. Kobayashi Y, Fujimoto T, Shiiki H, Kitaoka K, Murata K, Dohi K. Focal eosinophilic myositis. Clin Rheumatol. 2001; 20:369–371.
Article
6. Matsuse D, Ikezoe K, Shigeto H, Murai H, Ohyagi Y, Kira J. Case of eosinophilic myositis in continuum from localized nodular myositis. Rinsho Shinkeigaku. 2008; 48:36–42.